A new naturally occurring erythromycin: erythromycin F.
Jerry R. Martin, R. LARRY DEVAULT, Arthur C. Sinclair, RUTH S. STANASZEK, PAULETTE JOHNSON
Abstract
Open-access reader
Jerry R. Martin, R. LARRY DEVAULT, Arthur C. Sinclair, RUTH S. STANASZEK, PAULETTE JOHNSON
Abstract
Open-access reader
A new erythromycin, designated erythromycin F, was isolated from the mother liquors of an early commercial strain of Streptomyces erythreus. Although not established experimentally, erythromycin F may be a biosynthetic precursor of erythromycin E.
OpenAlex reports 28 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A new erythromycin, designated erythromycin F, was isolated from the mother liquors of an early commercial strain of Streptomyces erythreus. Although not established experimentally, erythromycin F may be a biosynthetic precursor of erythromycin E.
Key concepts: Erythromycin, Strain (injury), Microbiology, Streptomyces, Antibiotics, Chemistry, Biology, Bacteria